Second-line Irinotecan Liposome Combination Regimen for Irinotecan-treated Pancreatic Cancer
Clinical trial NCT06700603 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06700603
- Sponsor
- Rui-hua Xu, MD, PhD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-20
- Primary completion
- 2025-12-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.